INS and Parkinson disease: Furthermore, growing evidence has shown that insulin signaling pathway disruptions may play a major role in the pathogenesis of PD, including inflammation, oxidative stress, and increased α-synuclein deposition in the brain, which are associated with poor prognosis (Kim et al., 2011; Athauda and Foltynie, 2016).